#DYK that insomnia is the most common specific sleep disorder in the US? At #SLEEP2022, we look forward to discussing the latest in sleep medicine, including how #PDTs can support people with chronic #insomnia. Set up a meeting to learn more.
Hearing @DrGupta46’s firsthand experience of practicing medicine on the frontlines of the addiction crisis at #NAATP2022 reminds us why compassionate, accessible, and effective care is key to ending the epidemic and improving the health of our communities.
What a great turnout at our @amcporg Partner Session! Our CMO @ymaricich, Jeff Berkowitz of @RealEndpoints, Pat Gleason of @Prime_PBM and Dr. Arwen Podesta shared interesting insights around the reimbursement landscape and approaches to evaluating coverage for #PDTs. #AMCP2022
Learn how CTS can support early #marketaccess planning by predicting a range of feasible trial results while making it possible to anticipate challenges to the #economicvalue story of new treatments that may result: https://t.co/WQbxyoJN7Q
Upcoming webinar Oct 18: Evidera has developed an oncology value frameworks tool that allows the user to compare their product's value across various frameworks (NCCN, ASCO, ESMO, MSKCC, ICER). Register today: https://t.co/GCSFJsatIW